Toxic Features and Metabolomic Intervention of Glabrene, an Impurity Found in the Pharmaceutical Product of Glabridin.
Xue LiHaixin JiangDongxue GuoWen HuangHoupu RenQiang ZhangPublished in: International journal of molecular sciences (2024)
Glabridin is a widely used product in the cosmetics and pharmaceutical industry, which is generally isolated and purified from Licorice ( Glycyrrhiza glabra ) extract in industrial production. It has wide clinical applications, but significant toxicity has also been reported. The purity of glabridin raw material is generally between 90% and 98%. We have identified a toxic impurity, glabrene, in the industrial product glabridin. Our investigation using an AB wild-type zebrafish toxicity test showed that glabrene has a significant lethal effect with an LC 10 of 2.8 μM. Glabrene induced obvious malformation and disrupted cartilage development in zebrafish larvae. Furthermore, the compound significantly reduced larval mobility and caused damage to brain neural tissues. Metabolic pathway analysis and neurotransmitter quantification via ELISA indicated abnormal activation of the phenylalanine metabolic pathway, resulting in elevated dopamine and acetylcholine levels in vivo. These findings provide insights into the potential risks of glabrene contamination and offer a new reference point for enhancing safety measures and quality controls in licorice-derived products.
Keyphrases
- oxidative stress
- wild type
- human health
- diabetic rats
- wastewater treatment
- heavy metals
- resting state
- risk assessment
- randomized controlled trial
- aedes aegypti
- drosophila melanogaster
- gene expression
- white matter
- functional connectivity
- uric acid
- health risk
- drinking water
- climate change
- mass spectrometry
- extracellular matrix
- metabolic syndrome
- monoclonal antibody
- oxide nanoparticles
- endothelial cells
- data analysis
- high resolution